Comparative outcomes of severe obstructive sleep apnea in pediatric patients with Trisomy 21

Area of Science:

• Pediatric Otolaryngology
• Sleep Medicine
• Genetics

Background:

• Severe obstructive sleep apnea (OSA) is a significant concern in pediatric populations.
• Trisomy 21 (Down syndrome) is associated with a higher prevalence of OSA.
• Outcomes of OSA treatment in syndromic versus non-syndromic children require further analysis.

Purpose of the Study:

• To compare the treatment outcomes of severe OSA in pediatric patients with Trisomy 21 against non-syndromic pediatric patients.
• To evaluate differences in subjective and objective outcomes, perioperative care, and healthcare utilization.

Main Methods:

• Retrospective chart review of patients diagnosed with severe OSA (Apnea-Hypopnea Index ≥ 10).
• Comparison between pediatric patients with Trisomy 21 and non-syndromic patients.
• Analysis of preoperative and postoperative Apnea-Hypopnea Index, surgical interventions, and hospital stay duration.

Main Results:

• No significant difference in preoperative Apnea-Hypopnea Index between groups.
• Post-treatment Apnea-Hypopnea Index reduction was less substantial in the Trisomy 21 group (26.6 to 11.6) compared to the non-syndromic group (24.5 to 3.6).
• Complete resolution of OSA occurred in 35% of Trisomy 21 patients versus 75% of non-syndromic patients. The Trisomy 21 group had a longer average hospital stay (3.8 vs 1.7 days).

Conclusions:

• Pediatric patients with Trisomy 21 and severe OSA often experience residual symptoms after surgical intervention.
• These patients face an increased risk of requiring post-operative airway interventions.
• A longer hospital stay is a notable outcome for Trisomy 21 patients undergoing OSA treatment.